The program is specifically designed to enhance current knowledge about the prevention, intervention and management of cardiovascular disease (CVD). Presentations will provide Advanced Practice Nurses, Physician Assistants and Clinical Nurses with evidence-based approaches regarding treatment of advance heart failure, lipid management, cardio-oncology and mental health in patients with coronary artery disease (CAD). Lectures will include hemodynamics, LV assist device as therapy for complex valve disease, patients’ journey through heart transplantation, electrocardiogram (EKG) review, establishing genetic links in CAD, research reviews in diabetes mellitus (DM) and CVD.
Provide the Advanced Practice Nurses, Physician Assistants and Clinical Nurses the current knowledge in the prevention, intervention and management of CVD.
This education activity is pending approval by the American Association of Nurse Practitioners of up to 9.25 total contact hours with 4.5 accredited pharmacology content. This program was planned in accordance with AANP CE Standards and Policies.
It is the policy of The Icahn School of Medicine at The Mount Sinai Hospital to ensure objectivity, balance, independence, transparency, and scientific rigor in all sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship.
Presenters must also make a meaningful disclosure to the audience about their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the course materials.